Key facts
- Pinch (Clinics/Outpatient Services)’s last known valuation is $38.0M (May 2025).
- It has raised $13.7M; the latest was Seed Round ($9.4M) in May 2025.
- Notable investors include FJ Labs, Ludlow Ventures, Lightbank (Venture Capital), Starting Line, Hyde Park Venture Partners — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Pinch (Clinics/Outpatient Services)
- ·The full record, as it builds
Funding rounds
No funding rounds for Pinch (Clinics/Outpatient Services) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pinch (Clinics/Outpatient Services)
Operator of an on-demand cosmetic injection platform intended to provide a youthful, radiant complexion. The company's platform serves as a mobile cosmetic injectables to consult, schedule, select and book treatment sessions for botulinum injectable and dermal filler procedures that are done at the home, office or even hotel, enabling customers with a medically trained and licensed nurse practitioner to perform the procedure at their convenience and with privacy.
- Sector
- Healthcare
- HQ
- Evanston, IL, United States
- Founded
- 2021
- Employees
- 6
- Website
- bookpinch.com/
- Ownership
- Privately Held (backing)
Pinch (Clinics/Outpatient Services) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pinch (Clinics/Outpatient Services) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pinch (Clinics/Outpatient Services) in its N-PORT filings yet. We sweep new filings monthly.